Richard Mahoney - Jan 3, 2024 Form 4 Insider Report for SYNOPSYS INC (SNPS)

Role
Chief Revenue Officer
Signature
By: POA Pursuant Liz Ramirez For: Richard Mahoney
Stock symbol
SNPS
Transactions as of
Jan 3, 2024
Transactions value $
-$3,072,291
Form type
4
Date filed
1/4/2024, 12:19 PM
Previous filing
Dec 14, 2023
Next filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNPS Common Stock Options Exercise $1.41M +4.42K +70.69% $319.20 10.7K Jan 3, 2024 Direct
transaction SNPS Common Stock Sale -$2.19M -4.42K -41.42% $494.68 6.26K Jan 3, 2024 Direct F1
transaction SNPS Common Stock Sale -$2.3M -4.64K -74.16% $494.72 1.62K Jan 3, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNPS Non-Qualified Stock Option (right to buy) Options Exercise $0 -4.42K -18.75% $0.00 19.2K Jan 3, 2024 Common Stock 4.42K $319.20 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $492.053 to $496.500. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 13, 2023.
F3 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.